Patent · US Active

Triaza-spirodecanones as DDR1 inhibitors

US10435407B2 · kind B2 · utility

0Cited by
5References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 4, 2019
Grant dateOct 8, 2019
Priority date—
Expiry dateFeb 4, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D519/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.